212 related articles for article (PubMed ID: 22314183)
21. Microsatellite instability in poorly differentiated adenocarcinomas of the colon and rectum: relationship to clinicopathological features.
Kazama Y; Watanabe T; Kanazawa T; Tanaka J; Tanaka T; Nagawa H
J Clin Pathol; 2007 Jun; 60(6):701-4. PubMed ID: 17557871
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical staining for c-Kit (CD117) is a rare event in human colorectal carcinoma.
Reed J; Ouban A; Schickor FK; Muraca P; Yeatman T; Coppola D
Clin Colorectal Cancer; 2002 Aug; 2(2):119-22. PubMed ID: 12453327
[TBL] [Abstract][Full Text] [Related]
23. Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer.
Bettstetter M; Woenckhaus M; Wild PJ; Rümmele P; Blaszyk H; Hartmann A; Hofstädter F; Dietmaier W
J Pathol; 2005 Apr; 205(5):606-14. PubMed ID: 15714592
[TBL] [Abstract][Full Text] [Related]
24. Neuroendocrine carcinoma of the stomach: morphologic and immunohistochemical characteristics and prognosis.
Ishida M; Sekine S; Fukagawa T; Ohashi M; Morita S; Taniguchi H; Katai H; Tsuda H; Kushima R
Am J Surg Pathol; 2013 Jul; 37(7):949-59. PubMed ID: 23759931
[TBL] [Abstract][Full Text] [Related]
25. Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability.
Ward RL; Cheong K; Ku SL; Meagher A; O'Connor T; Hawkins NJ
J Clin Oncol; 2003 Oct; 21(20):3729-36. PubMed ID: 14551292
[TBL] [Abstract][Full Text] [Related]
26. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.
An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ
Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071
[TBL] [Abstract][Full Text] [Related]
27. CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer.
Kim HC; Roh SA; Ga IH; Kim JS; Yu CS; Kim JC
J Gastroenterol Hepatol; 2005 Dec; 20(12):1920-6. PubMed ID: 16336454
[TBL] [Abstract][Full Text] [Related]
28. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
[TBL] [Abstract][Full Text] [Related]
29. Analysis of protein expression and gene mutation of c-kit in colorectal neuroendocrine carcinomas.
Akintola-Ogunremi O; Pfeifer JD; Tan BR; Yan Y; Zhu X; Hart J; Goldblum JR; Burgart L; Lauwers GY; Montgomery E; Lewin D; Washington K; Bronner M; Xiao SY; Greenson JK; Lamps L; Lazenby A; Wang HL
Am J Surg Pathol; 2003 Dec; 27(12):1551-8. PubMed ID: 14657715
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of neuroendocrine components in gastric carcinomas.
Park JY; Ryu MH; Park YS; Park HJ; Ryoo BY; Kim MG; Yook JH; Kim BS; Kang YK
Eur J Cancer; 2014 Nov; 50(16):2802-9. PubMed ID: 25201164
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of MS-MLPA in DNA methylation profiling of adenocarcinomas and neuroendocrine carcinomas of the colon-rectum.
Furlan D; Sahnane N; Mazzoni M; Pastorino R; Carnevali I; Stefanoli M; Ferretti A; Chiaravalli AM; La Rosa S; Capella C
Virchows Arch; 2013 Jan; 462(1):47-56. PubMed ID: 23224118
[TBL] [Abstract][Full Text] [Related]
32. Gastric mixed adenoneuroendocrine carcinoma: correlation of histologic characteristics with prognosis.
Nie L; Li M; He X; Feng A; Wu H; Fan X
Ann Diagn Pathol; 2016 Dec; 25():48-53. PubMed ID: 27806846
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of diagnosing colorectal neuroendocrine carcinoma using the World Health Organization 2010 classification.
Lee JL; Yu CS; Kim M; Hong SM; Lim SB; Kim JC
Surgery; 2014 Apr; 155(4):650-8. PubMed ID: 24468036
[TBL] [Abstract][Full Text] [Related]
34. Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma.
Conesa-Zamora P; García-Solano J; García-García F; Turpin Mdel C; Trujillo-Santos J; Torres-Moreno D; Oviedo-Ramírez I; Carbonell-Muñoz R; Muñoz-Delgado E; Rodriguez-Braun E; Conesa A; Pérez-Guillermo M
Int J Cancer; 2013 Jan; 132(2):297-307. PubMed ID: 22696308
[TBL] [Abstract][Full Text] [Related]
35. The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories.
Milione M; Maisonneuve P; Spada F; Pellegrinelli A; Spaggiari P; Albarello L; Pisa E; Barberis M; Vanoli A; Buzzoni R; Pusceddu S; Concas L; Sessa F; Solcia E; Capella C; Fazio N; La Rosa S
Neuroendocrinology; 2017; 104(1):85-93. PubMed ID: 26943788
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas.
Koh J; Nam SK; Kwak Y; Kim G; Kim KK; Lee BC; Ahn SH; Park DJ; Kim HH; Park KU; Kim WH; Lee HS
J Pathol; 2021 Jan; 253(1):94-105. PubMed ID: 32985687
[TBL] [Abstract][Full Text] [Related]
37. Expression of squamous cell carcinoma markers and adenocarcinoma markers in primary pulmonary neuroendocrine carcinomas.
Masai K; Tsuta K; Kawago M; Tatsumori T; Kinno T; Taniyama T; Yoshida A; Asamura H; Tsuda H
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):292-7. PubMed ID: 23060301
[TBL] [Abstract][Full Text] [Related]
38. Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumor.
Takizawa N; Ohishi Y; Hirahashi M; Takahashi S; Nakamura K; Tanaka M; Oki E; Takayanagi R; Oda Y
Hum Pathol; 2015 Dec; 46(12):1890-900. PubMed ID: 26434631
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal mixed adenoneuroendocrine carcinoma (MANEC): An immunohistochemistry study of 13 microsatellite stable cases.
Gurzu S; Fetyko A; Bara T; Banias L; Butiurca VO; Bara T; Tudorache V; Jung I
Pathol Res Pract; 2019 Dec; 215(12):152697. PubMed ID: 31704155
[TBL] [Abstract][Full Text] [Related]
40. CD117, Ki-67, and p53 predict survival in neuroendocrine carcinomas, but not within the subgroup of small cell lung carcinoma.
Erler BS; Presby MM; Finch M; Hodges A; Horowitz K; Topilow AA; Matulewicz T
Tumour Biol; 2011 Feb; 32(1):107-11. PubMed ID: 21058037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
